“NQF’s recent endorsement of 11 quality measures of patient safety includes three measures developed by the Pharmacy Quality Alliance (PQA) to address the use of opioids at high dosage or from multiple providers, with appropriate exclusions, including cancer patients. These are the first NQF-endorsed measures intended to address the nation’s devastating—and growing—opioid epidemic. Each was thoughtfully considered and, ultimately, recommended for endorsement by NQF’s Patient Safety Standing Committee…”
NQF Statement on Endorsement of Opioid Patient Safety Measures
More from United StatesMore posts in United States »
- Study Finds CMS Hospital Ratings Highly Sensitive to Methodological Choices in Calculation
- CMS Proposed Rule to Suppress Public Reporting of Key Measures of Preventable Hospital-Caused Harm
- Call for Hospitals to Make Radical Transparency Real and Accessible to Improve Patient Safety
- NQF Begins Accepting Public Comments to Review Quality Measures Used in Federal Programs
- Cancer Death Rates Among Black People Declined Over Time, Remains Higher Than Other Racial and Ethnic Groups